Heather Malcolm
Directeur/Bestuurslid bij Montana Council on Economic Education
Profiel
Heather Malcolm is currently the Director at Montana Council on Economic Education.
Prior to this, she worked as the Vice President-Human Resources at Lundbeck Seattle BioPharmaceuticals, Inc. from 2008 to 2019.
Ms. Malcolm completed her undergraduate degree from St. John's College in 1994.
Actieve functies van Heather Malcolm
Bedrijven | Functie | Begin |
---|---|---|
Montana Council on Economic Education
Montana Council on Economic Education Investment Trusts/Mutual FundsMiscellaneous Montana Council on Economic Education focuses on teacher education. The firm hosts training sessions throughout the year including workshops, conferences and seminars. Its programs include Teacher Training, High School Business Challenge, and The Stock Market Game. The company is headquartered in Bozeman, MT. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Heather Malcolm
Bedrijven | Functie | Einde |
---|---|---|
ALDER BIOPHARMACEUTICALS, INC. | Human Resources Officer | 01-12-2019 |
Opleiding van Heather Malcolm
St. John's College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Montana Council on Economic Education
Montana Council on Economic Education Investment Trusts/Mutual FundsMiscellaneous Montana Council on Economic Education focuses on teacher education. The firm hosts training sessions throughout the year including workshops, conferences and seminars. Its programs include Teacher Training, High School Business Challenge, and The Stock Market Game. The company is headquartered in Bozeman, MT. | Miscellaneous |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |